STAT

I’m an ambassador to nightmares. My medical training didn’t prepare me for that

As an emergency physician, I sometimes escort families into sadness and despair, plunging them into the darkest emotional depths with the news I must give.

I’m a physician, a husband and dad, a guy who tries to live by the golden rule. But sometimes I’m an escort into sadness and despair, plunging families into the darkest emotional depths with the news I must give.

One particular case from years prior stands out. Mary (whose name and identifying details have been altered) would have been starting college in a few weeks. Instead, the car in which she was a passenger collided with a truck. My emergency department team couldn’t resuscitate her. Right after we called the time of death, a nurse gasped. With a shaking hand, she pointed to Mary’s cell, which we had removed from her jeans when we cut off her clothes. “Where are you!!” the text message said. It was from Dad.

Later on, as I sit in the windowless family room packed with a chair, two small

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks